The effect of linear polirazed polychromatic light therapy on pressure ulcers

Amaç: Bası yaralarının iyileşmesinde lineer polarize polikromatik ışık (LPPI) tedavisinin etkinliği araştırıldı. Hastalar ve Yöntemler: Evre II ve evre III bası yaraları olan 40 hasta rastgele olarak LPPI tedavisi ve konvansiyonel tedavi (kontrol) gruplarına ayrıldı. Tüm yaralara serum fizyolojikle yıkama ve antibakteriyel pomat tedavisi uygulandı. Birinci grubu oluşturan hastalara bu uygulama sonrası Biolamp cihazıyla günde bir kez, 6 dk ve 10 cm uzaklıktan, direkt cilt üzerine 1.3 J/cm2 enerji dozunda LPPI tedavisi yapıldı. Bası yaralarının yüzey alanları, tedavi başlangıcında (birinci gün), yedinci gün ve 15. günlerde milimetrik grafik kâğıdına aktarıldı. Çizim sınırları içinde kalan kareler sayılarak, yüzey alanı cm2 olarak hesaplandı. Bulgular: Tedavi öncesi, birinci, yedinci ve 15. günlerde yapılan grup içi değerlendirmelerde her iki tedavi yönteminin de etkili olduğu görüldü ve sonuçlar istatistiksel olarak anlamlı bulundu (p<0.05). Ancak, LPPI tedavisinin daha etkili olduğu ve geniş yaralarda daha kısa sürede iyileşme sağladığı görüldü. Sonuç: Bulgularımız, evre II ve evre III bası yaraları nın tedavisinde LPPI uygulamasının daha hızlı iyileşme sağladığını göstermektedirObjectives: We assessed the effect of linear polarized polychromatic light (LPPL) on the healing of pressure ulcers. Patients and Methods: Forty patients with grade II or grade III pressure ulcers were randomly assigned to LPPL or conventional therapies. All wound surfaces were cleaned using physiologic serum and dressed with antibacterial pomade. Linear polarized polychromatic light was applied directly through the skin with the Biolamp device, at a dose of 1.3 J/cm2 for 6 minutes daily from a distance of 10 cm. Ulcer area measurements were calculated as square centimeters on a graph paper at baseline and on the seventh and 15th days of treatment. Results: Comparisons of mean wound areas within each group showed significant improvements on the seventh and 15th days of treatment (p&lt;0.05). However, it was noted that healing of larger wound areas was faster and more effective in patients treated with LPPL. Conclusion: Our results suggest that LPPL is more effective in treating grade II and grade III pressure wounds

Efficiency of Magnetic Field Treatment on Pressure Sores in Bedridden Patients

Objective: Pressure sores are an important source of complications in patients who are immobilized and bedridden. We aimed to investigate the efficiency of magnetic field treatment in pressure sores. Material and Methods: This was a randomized, double blind controlled design study. 20 patients in the study group received magneto-therapy, once a day for 30 minutes and with 150G, keeping to the BTL09 magnetotherapy device’s program. In the control group, 20 patients received the dressing only once a day. The surface areas of the pressure sores were evaluated at the onset of the treatment (1st day), and on the 7th and 15th days.Results: When within group comparisons were conducted, a significant difference was observed between the 1st and 7th day, 7th and 15th day, and 1st and 15th day measures in both the groups in terms of the scar area. The average healing time for the treatment group was 10.80±4.06 (6-20) days, and the average healing time for the control group was 18.85±9.75 (5-32) days. There was a statistically significant difference between the two groups (z=-2.114, p=0.034). Also, there was a significant difference in the scar area between the two groups in the 15th day measure (z=-3.818, p=0.000).Conclusion: The healing process of the tissue can be accelerated.with the use of magnetotherapy in the treatment of pressure sores of stage II and III

A prospective observational evaluation of treatment outcomes of patients with chronic obstructive pulmonary disease and peripheral blood eosinophilia Kronik obstrüktif akciğer hastalığı ve periferik kan eozinofilisi olan hastaların tedavi sonuçlarının prospektif gözlemsel değerlendirilmesi

© 2021.Introduction: This study aimed to compare two groups of patients with Chronic Obstructive Lung Disease (COPD) and blood eosinophil values of ≥300 cells/ µL. The patients were followed up for one year in two groups, one receiving inhaled corticosteroids (ICS) and the other not receiving ICS in terms of exacerbation rates, the incidence of pneumonia, mortality rates, FEV1, FVC and FEF25-75 changes, the COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores. Materials and Methods: Stable patients, who presented to the University Medical Faculty Chest diseases outpatient clinic and diagnosed with COPD according to pulmonary function test results and GOLD stages 2-4 according to the 2017 GOLD criteria and with blood eosinophil counts of ≥ 300 cells/ µL were included in the study. Results: 85 patients were included in the study, of which 76.5% (n= 65) were males. There were no significant differences between the 38 patients receiving ICS and the 47 patients not receiving ICS regarding baseline FEV1, FVC, FEF25- 75absolute values and percentages, and FEV1, FVC values controlled at month six and month 12, and FEF25-75 absolute values and percentages at month six (p> 0.05). However, the difference between the baseline and month 12 absolute values and percentages of FEF25-75 was statistically significant, and the decrease from baseline was greater in the group receiving ICS (p 0.05). Conclusion: In this study, it was determined that exacerbation rates of eosinophilic COPD patients did not differ depending on the use of ICS in a one-year period. Nevertheless, the 12-month FEF25-75 values of patients not using ICS were lower to a lesser extent, while the CAT and mMRC scores improved in favor of ICS users at different months in the one-year follow-up

Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report

BACKGROUN

Prolonged Control of Hypercalcemia Due to Inoperable Parathyroid Carcinoma by Cinacalcet in a Dialysis Patient

Parathyroid carcinoma is a rare malignancy and an infrequent cause of parathormone-dependent hypercalcemia. The most effective treatment for the tumor is a complete resection of the primary tumor. In spite of this, the tumor usually recurs. In the present study, we report the case of a 42-year-old patient who has undergone continuous ambulatory peritoneal dialysis and presented with hypercalcemia due to inoperable parathyroid carcinoma. The patient's hypercalcemia was successfully controlled with cinacalcet plus alendronate despite continuing parathyroid hormone overproduction